Product information and disease descriptionPlace of product in therapyDisease description
Burden of Fibrodysplasia ossificans progressiva
25 evidence topics · 12 sources
Atebrioz (zilurgisertib)
Fibrodysplasia ossificans progressiva
- Manufacturer
- Mirum Pharmaceuticals
- Regulatory submission
- NDA submitted by May 2026
- Last updated